1. Home
  2. CVM vs SYT Comparison

CVM vs SYT Comparison

Compare CVM & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • SYT
  • Stock Information
  • Founded
  • CVM 1983
  • SYT 2010
  • Country
  • CVM United States
  • SYT Japan
  • Employees
  • CVM N/A
  • SYT N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • SYT Real Estate
  • Sector
  • CVM Health Care
  • SYT Finance
  • Exchange
  • CVM Nasdaq
  • SYT Nasdaq
  • Market Cap
  • CVM 40.1M
  • SYT 40.2M
  • IPO Year
  • CVM 1987
  • SYT 2023
  • Fundamental
  • Price
  • CVM $0.71
  • SYT $1.96
  • Analyst Decision
  • CVM
  • SYT
  • Analyst Count
  • CVM 0
  • SYT 0
  • Target Price
  • CVM N/A
  • SYT N/A
  • AVG Volume (30 Days)
  • CVM 987.3K
  • SYT 34.1K
  • Earning Date
  • CVM 02-12-2025
  • SYT 09-27-2024
  • Dividend Yield
  • CVM N/A
  • SYT 0.35%
  • EPS Growth
  • CVM N/A
  • SYT N/A
  • EPS
  • CVM N/A
  • SYT 0.08
  • Revenue
  • CVM N/A
  • SYT $149,124,408.00
  • Revenue This Year
  • CVM N/A
  • SYT N/A
  • Revenue Next Year
  • CVM $3,412.81
  • SYT N/A
  • P/E Ratio
  • CVM N/A
  • SYT $25.10
  • Revenue Growth
  • CVM N/A
  • SYT 3.11
  • 52 Week Low
  • CVM $0.49
  • SYT $1.43
  • 52 Week High
  • CVM $3.23
  • SYT $8.74
  • Technical
  • Relative Strength Index (RSI)
  • CVM 51.45
  • SYT 58.54
  • Support Level
  • CVM $0.60
  • SYT $1.68
  • Resistance Level
  • CVM $0.82
  • SYT $2.15
  • Average True Range (ATR)
  • CVM 0.12
  • SYT 0.25
  • MACD
  • CVM 0.01
  • SYT 0.02
  • Stochastic Oscillator
  • CVM 36.28
  • SYT 69.31

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About SYT SYLA Technologies Co. Ltd.

SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.

Share on Social Networks: